DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
0.9% sodium chloride solution (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
77 days-105 days |
12 |
0.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
97071 |
1158 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
77 days-105 days |
10 |
50.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
69551 |
1158 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
joint integrity trait |
both |
66 days-126 days |
105 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
immunized |
10 |
days |
variable |
|
|
69959 |
850 |
DA/Bkl |
calculated serum anti-porcine type 2 collagen antibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood immunoglobulin amount |
both |
66 days-126 days |
105 |
19.0 |
null |
0.59 |
6.0 |
enzyme linked immunosorbent assay |
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69962 |
850 |
DA/Bkl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89 days-95 days |
9 |
4.7 |
% |
1.0 |
3.0 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
|
107183 |
3077 |
DA/Bkl |
body weight loss |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
body mass |
both |
66 days-126 days |
105 |
19.0 |
% |
0.49 |
5.0 |
body weighing method |
0.0 |
immunized |
10 |
days |
variable |
(weight loss) |
|
69960 |
850 |
DA/Bkl |
calculated serum anti-rat type 2 collagen autoantibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood autoantibody amount |
both |
66 days-126 days |
105 |
15.0 |
null |
0.59 |
6.0 |
enzyme linked immunosorbent assay |
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69963 |
850 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. |
joint integrity trait |
male |
63 days-126 days |
15 |
100.0 |
% |
|
|
in vivo visual assessment |
3024000.0 |
|
0 |
|
|
|
|
70146 |
1299 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
joint integrity trait |
both |
66 days-126 days |
105 |
15.0 |
d |
0.2 |
2.0 |
in vivo visual assessment |
0.0 |
immunized |
10 |
days |
variable |
|
|
68143 |
850 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. |
joint integrity trait |
female |
63 days-126 days |
14 |
100.0 |
% |
|
|
in vivo visual assessment |
3024000.0 |
|
0 |
|
|
|
|
70147 |
1299 |
DA/Bkl |
plasma corticosterone level |
controlled exposure to ambient light (for 12 hours) |
Potenza MN, et al., Biol Psychiatry 2004 Mar 15;55(6):634-41. |
blood corticosterone amount |
male |
0 days
| 11 |
47.39 |
ng/ml |
10.77 |
35.72 |
radioimmunoassay |
0.0 |
|
0 |
|
|
|
|
68639 |
970 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
77 days-105 days |
12 |
83.3 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
69552 |
1158 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
70 days-105 days |
10 |
14.4 |
d |
1.3 |
4.11 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
69554 |
1158 |
DA/Bkl |
percentage of study population developing experimental arthritis during a period of time |
0.9% sodium chloride solution (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
77 days-105 days |
10 |
0.0 |
% |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
97070 |
1158 |
DA/Bkl |
water intake drink rate to body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
drinking behavior trait |
male |
89 days-95 days |
9 |
0.98 |
ml/d/kg |
0.18 |
0.54 |
drink intake measuring method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
Water consumed
(g) postsurgery
per 100 g BW |
107162 |
3077 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
70 days-105 days |
12 |
15.8 |
d |
3.3 |
11.43 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
|
|
69553 |
1158 |